13F HOLDINGS REPORT
BVF INC/IL
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000921895-24-002698
Total Value
$3.42B
Positions
55
Other Managers
1
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 21,751,284 | $1.10B | 32.08% |
| 2 | KYMERA THERAPEUTICS INC | KYMR | 5,161,801 | $244.3M | 7.15% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 3,478,612 | $157.8M | 4.61% |
| 4 | MIRUM PHARMACEUTICALS INC | MIRM | 3,075,907 | $120.0M | 3.51% |
| 5 | TYRA BIOSCIENCES INC | TYRA | 4,661,194 | $109.6M | 3.21% |
| 6 | OLEMA PHARMACEUTICALS INC | OLMA | 9,135,893 | $109.1M | 3.19% |
| 7 | STRUCTURE THERAPEUTICS INC | GPCR | 2,238,986 | $98.3M | 2.87% |
| 8 | CULLINAN THERAPEUTICS INC | CGEM | 5,750,683 | $96.3M | 2.82% |
| 9 | XOMA ROYALTY CORPORATION | XOMAP | 3,633,743 | $96.2M | 2.81% |
| 10 | AXSOME THERAPEUTICS INC | AXSM | 1,046,000 | $94.0M | 2.75% |
| 11 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,850,167 | $83.3M | 2.44% |
| 12 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 7,382,642 | $79.8M | 2.33% |
| 13 | AC IMMUNE SA | ACIU | 19,522,436 | $73.8M | 2.16% |
| 14 | GH RESEARCH PLC | GHRS | 10,400,158 | $69.6M | 2.04% |
| 15 | KURA ONCOLOGY INC | KURA | 3,371,761 | $65.9M | 1.93% |
| 16 | THIRD HARMONIC BIO INC | 88427A107 | 4,365,933 | $59.2M | 1.73% |
| 17 | IONIS PHARMACEUTICALS INC | IONS | 1,451,879 | $58.2M | 1.70% |
| 18 | ZYMEWORKS INC | ZYME | 4,607,935 | $57.8M | 1.69% |
| 19 | ESSA PHARMA INC | 29668H708 | 8,748,629 | $53.0M | 1.55% |
| 20 | AGIOS PHARMACEUTICALS INC | AGIO | 1,190,107 | $52.9M | 1.55% |
| 21 | CELCUITY INC | CELC | 3,466,000 | $51.7M | 1.51% |
| 22 | 89BIO INC | 282559103 | 6,811,631 | $50.4M | 1.47% |
| 23 | FOGHORN THERAPEUTICS INC | FHTX | 5,302,000 | $49.4M | 1.44% |
| 24 | GALAPAGOS NV | GLPGF | 1,569,422 | $45.2M | 1.32% |
| 25 | IDEAYA BIOSCIENCES INC | IDYA | 1,409,993 | $44.7M | 1.31% |
| 26 | ANNEXON INC | ANNX | 7,000,000 | $41.4M | 1.21% |
| 27 | CG ONCOLOGY INC | CGON | 994,596 | $37.5M | 1.10% |
| 28 | REPARE THERAPEUTICS INC | 760273102 | 10,333,600 | $35.5M | 1.04% |
| 29 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 1,521,948 | $25.3M | 0.74% |
| 30 | XENCOR INC | XNCR | 850,000 | $17.1M | 0.50% |
| 31 | ELEDON PHARMACEUTICALS INC | ELDN | 6,293,282 | $15.7M | 0.46% |
| 32 | TSCAN THERAPEUTICS INC | TCRX | 2,989,474 | $14.9M | 0.44% |
| 33 | ENGENE HOLDINGS INC | ENGNW | 2,251,037 | $14.9M | 0.43% |
| 34 | IMMUNIC INC | IMUX | 8,902,972 | $14.7M | 0.43% |
| 35 | ALLAKOS INC | 01671P100 | 16,552,417 | $10.8M | 0.32% |
| 36 | AVALO THERAPEUTICS INC | AVTX | 967,000 | $9.1M | 0.27% |
| 37 | IKENA ONCOLOGY INC | 45175G108 | 4,769,164 | $8.3M | 0.24% |
| 38 | CIDARA THERAPEUTICS INC | 171757206 | 703,065 | $7.6M | 0.22% |
| 39 | CYTOMX THERAPEUTICS INC | CTMX | 5,228,461 | $6.2M | 0.18% |
| 40 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,813,633 | $6.2M | 0.18% |
| 41 | VISTAGEN THERAPEUTICS INC | VTGN | 2,000,000 | $6.0M | 0.18% |
| 42 | VERASTEM INC | VSTM | 1,685,219 | $5.0M | 0.15% |
| 43 | OVID THERAPEUTICS INC | OVID | 3,853,818 | $4.5M | 0.13% |
| 44 | PIERIS PHARMACEUTICALS INC | 720795202 | 257,626 | $4.3M | 0.13% |
| 45 | VERVE THERAPEUTICS INC | 92539P101 | 650,000 | $3.1M | 0.09% |
| 46 | SAB BIOTHERAPEUTICS INC | SABSW | 917,826 | $2.5M | 0.07% |
| 47 | MOLECULAR PARTNERS AG | MOLN | 443,221 | $2.1M | 0.06% |
| 48 | ELEVATION ONCOLOGY INC | 28623U101 | 2,966,836 | $1.8M | 0.05% |
| 49 | GLYCOMIMETICS INC | 38000Q102 | 9,544,262 | $1.6M | 0.05% |
| 50 | INVENTIVA SA | IVEVF | 686,040 | $1.3M | 0.04% |
| 51 | TENAX THERAPEUTICS INC | TENX | 339,549 | $1.2M | 0.03% |
| 52 | ENGENE HOLDINGS INC | ENGNW | 945,402 | $803,686 | 0.02% |
| 53 | MOLECULAR TEMPLATES INC | 608550208 | 522,238 | $733,744 | 0.02% |
| 54 | NLS PHARMACEUTICS LTD | H57830137 | 143,676 | $728,437 | 0.02% |
| 55 | FORTE BIOSCIENCES INC | FBRX | 119,282 | $667,979 | 0.02% |